EMEA-002452-PIP01-18 - paediatric investigation plan
Marizomib
PIPHuman
Celgene Europe B.V.
Tel. +41 327298500
E-mail: medinfo.emea@celgene.com
P/0403/2019: EMA decision of 4 December 2019 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the refusal of a waiver for marizomib (EMEA-002452-PIP01-18)